SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013767
Filing Date
2023-05-11
Accepted
2023-05-11 08:01:36
Documents
84
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20230331_10q.htm   iXBRL 10-Q 1477082
2 EXHIBIT 31.1 ex_470745.htm EX-31.1 17015
3 EXHIBIT 31.2 ex_470746.htm EX-31.2 17000
4 EXHIBIT 32.1 ex_470747.htm EX-32.1 6693
5 EXHIBIT 32.2 ex_470748.htm EX-32.2 6678
  Complete submission text file 0001437749-23-013767.txt   6233967

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20230331.xsd EX-101.SCH 67052
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20230331_cal.xml EX-101.CAL 49785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20230331_def.xml EX-101.DEF 370424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20230331_lab.xml EX-101.LAB 318834
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20230331_pre.xml EX-101.PRE 406185
78 EXTRACTED XBRL INSTANCE DOCUMENT urgn20230331_10q_htm.xml XML 800671
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 23908930
SIC: 2834 Pharmaceutical Preparations